Star Health and Allied Insurance Company Limited has informed the stock exchanges of virtual analyst and institutional investor meetings scheduled for May 07 and May 08, 2026, both pertaining to Q4 FY26. The disclosures were filed on May 04, 2026, from Chennai, in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

Meeting Overview

The company has scheduled virtual meetings with analysts and institutional investors across two days. The May 07 session involves a single firm, while May 08 features multiple group sessions as part of the J.P. Morgan Asia Insurance Forum. The following table summarises the key parameters of both days:

The company has noted that both meetings are subject to changes that may occur due to exigencies on the part of the analysts or investors.

May 08 Group Session Details

The May 08 meetings at the J.P. Morgan Asia Insurance Forum are structured as two separate group sessions, each featuring multiple institutional investors and asset managers. The participants across both sessions are detailed below.

Session 1 — Time (IST): 11:30 AM – 12:20 PM

Session 2 — Time (IST): 1:30 PM – 2:20 PM

Presentation Access

A presentation related to the meetings has been made available for access. The link to the presentation document — https://d28c6jni2fmamz.cloudfront.net/ECPQ_4_FY_26_10bb34a04c.pdf — has been shared as part of the regulatory disclosure. The above disclosures will also be made available on the company's website at www.starhealth.in .

Regulatory Compliance

Both filings were submitted to BSE Limited and the National Stock Exchange of India Limited as part of the company's ongoing listing obligations. The disclosures were signed by Jayashree Sethuraman, Company Secretary & Compliance Officer, on May 04, 2026.

Star Health Insurance has published the audited standalone financial results for the quarter and year ended March 31, 2026 in Business Standard (English Edition) and Dinamani (Tamil Edition) newspapers, complying with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification, dated April 30, 2026, was submitted to BSE Limited and National Stock Exchange of India Limited under reference number SHAI/B & S/SE/17/2026-27.

Financial Results Summary

The health insurer reported total income from operations of ₹18,62,192 lakhs for the year ended March 31, 2026, compared to ₹16,78,136 lakhs in the previous year. For the quarter ended March 31, 2026, total income from operations stood at ₹5,96,840 lakhs against ₹5,13,801 lakhs in the corresponding period of the previous year.

Quarterly Performance

For the three months ended March 31, 2026, the company recorded a net profit after tax of ₹11,134 lakhs, a significant improvement from ₹51 lakhs in the same quarter of the previous year. The net profit before tax stood at ₹15,121 lakhs compared to a loss of ₹87 lakhs in Q4 FY25.

Corporate Governance and Compliance

The financial results were reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on April 28, 2026. The Joint Statutory Auditors have audited the results. The disclosure was digitally signed by Jayashree Sethuraman, Company Secretary & Compliance Officer, ensuring compliance with stock exchange listing requirements. The complete financial results are available on the company's website at www.starhealth.in and on the stock exchange websites.